Literature DB >> 31326137

Uterine smooth muscle tumors of unknown malignant potential: A challenging question.

Angiolo Gadducci1, Gian Franco Zannoni2.   

Abstract

Uterine smooth muscle tumors of unknown malignant potential [STUMP]s are neoplasms with pathological features that preclude an equivocal diagnosis of leiomyosarcoma, but that do not fulfill the criteria for leiomyoma or its variants, and raise concerns that the tumors may behave in a malign fashion. Total hysterectomy with or without bilateral salpingo-oophorectomy is the standard treatment if fertility is completed, whereas myomectomy alone can be taken into consideration in young patients who desire to preserve childbearing potential. A careful surveillance every 6 months for 5 years and then yearly is strongly warranted. Patients with STUMP can relapse as either STUMP or leiomyosarcoma in approximately 11-13% of the cases, and their 5-year overall survival ranges from 92 to 100%. The present paper reviews the clinicopathological features of uterine STUMPs with a particular focus on most commonly accepted histopathological criteria for the diagnosis and on biological behaviour of these controversial neoplasms.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Histopathology; Molecular biomarkers; Smooth muscle tumor of unknown malignant potential; Surgery; Uterine sarcoma

Mesh:

Year:  2019        PMID: 31326137     DOI: 10.1016/j.ygyno.2019.07.002

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Multiple STUMPs in a 19-year-old woman: a rare case report.

Authors:  I Tsakiridis; D Evaggelinos; A Mamopoulos
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

Review 2.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

3.  Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.

Authors:  Fulvio Borella; Stefano Cosma; Domenico Ferraioli; Isabelle Ray-Coquard; Nicolas Chopin; Pierre Meeus; Vincent Cockenpot; Giorgio Valabrega; Giulia Scotto; Margherita Turinetto; Nicoletta Biglia; Luca Fuso; Luca Mariani; Dorella Franchi; Ailyn Mariela Vidal Urbinati; Ida Pino; Gianluca Bertschy; Mario Preti; Chiara Benedetto; Isabella Castellano; Paola Cassoni; Luca Bertero
Journal:  Ann Surg Oncol       Date:  2022-08-17       Impact factor: 4.339

4.  ASO Author Reflections: Surgical Management and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): New Insights.

Authors:  Fulvio Borella; Chiara Benedetto; Paola Cassoni; Luca Bertero
Journal:  Ann Surg Oncol       Date:  2022-08-17       Impact factor: 4.339

Review 5.  Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Systematic Review of the Literature.

Authors:  Jacopo Di Giuseppe; Camilla Grelloni; Lucia Giuliani; Giovanni Delli Carpini; Luca Giannella; Andrea Ciavattini
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

6.  Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.

Authors:  Lanqing Huo; Dan Wang; Wenze Wang; Dongyan Cao; Jiaxin Yang; Ming Wu; Junjun Yang; Yang Xiang
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

7.  Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.

Authors:  Donatella Conconi; Serena Redaelli; Andrea Alberto Lissoni; Chiara Cilibrasi; Patrizia Perego; Eugenio Gautiero; Elena Sala; Mariachiara Paderno; Leda Dalprà; Fabio Landoni; Marialuisa Lavitrano; Gaia Roversi; Angela Bentivegna
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

8.  An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls.

Authors:  Giuseppe Angelico; Angela Santoro; Frediano Inzani; Patrizia Straccia; Saveria Spadola; Damiano Arciuolo; Michele Valente; Nicoletta D'Alessandris; Roberta Benvenuto; Antonio Travaglino; Antonio Raffone; Gian Franco Zannoni
Journal:  Diagnostics (Basel)       Date:  2021-04-16

9.  Clinical and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single-center retrospective study.

Authors:  Chengcheng Ning; Lihong Zhang; Chenyan Zhao; Xiaojun Chen; Xiaoxia Liu; Chao Gu
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

10.  Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions.

Authors:  Garima Yadav; Meenakshi Rao; Shuchita Batra Goyal; Pratibha Singh; Priyanka Kathuria; Meenakshi Gothwal
Journal:  Obstet Gynecol Sci       Date:  2020-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.